Alexandra Hospital

I'm your host, Ryan Topping.

Today's episode features Dr. Thanos Dimopoulos from the University of Athens and Alexandra Hospital in Athens, Greece, and Dr. Maria Victoria Mateos from the University Hospital of Salamanca in Salamanca, Spain, as they discuss the use of cell mod agents to manage multiple myeloma, including the recent FDA approval of iverdamide, mechanism of action and differentiation of cell mods from image, and current data and potential treatment settings.

This episode is part of a larger educational program titled Novel Approaches in Relapsed Refractory Multiple Myeloma, Expert Perspectives on Emerging Data and Ongoing Trials.

For more information, along with a link to the larger education program, please visit the show notes for this episode.